febuxostat has been researched along with 2,8-dihydroxyadenine in 2 studies
| Studies (febuxostat) | Trials (febuxostat) | Recent Studies (post-2010) (febuxostat) | Studies (2,8-dihydroxyadenine) | Trials (2,8-dihydroxyadenine) | Recent Studies (post-2010) (2,8-dihydroxyadenine) |
|---|---|---|---|---|---|
| 818 | 133 | 710 | 153 | 0 | 24 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kimura, T; Kurosawa, A; Nanmoku, K; Shimizu, T; Shinzato, T; Yagisawa, T | 1 |
| Edvardsson, VO; Eiriksson, F; Goldfarb, DS; Oddsdottir, GS; Palsson, R; Runolfsdottir, HL; Sch Agustsdottir, IM; Thorsteinsdottir, M; Thorsteinsdottir, UA | 1 |
2 other study(ies) available for febuxostat and 2,8-dihydroxyadenine
| Article | Year |
|---|---|
Febuxostat for the Prevention of Recurrent 2,8-dihydroxyadenine Nephropathy due to Adenine Phosphoribosyltransferase Deficiency Following Kidney Transplantation.
Topics: Adenine; Adenine Phosphoribosyltransferase; Adult; Febuxostat; Gout Suppressants; Humans; Kidney Transplantation; Male; Metabolism, Inborn Errors; Urolithiasis | 2017 |
Comparison of the effect of allopurinol and febuxostat on urinary 2,8-dihydroxyadenine excretion in patients with Adenine phosphoribosyltransferase deficiency (APRTd): A clinical trial.
Topics: Adenine; Adenine Phosphoribosyltransferase; Adult; Aged; Allopurinol; Cross-Over Studies; Enzyme Inhibitors; Febuxostat; Female; Humans; Iceland; Kidney Calculi; Male; Metabolism, Inborn Errors; Middle Aged; Pilot Projects; Registries; Treatment Outcome; Urolithiasis | 2018 |